Spacer devices

Drug Delivery to the Lung

Volumn , Issue , 2001, Pages 389-420

  Bisgaard, Hans ^a   Anhøj, Jacob ^a   Wildhaber, Johannes H ^b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84964219078     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (100)

1. Franklin W, Lowell F, Michelson AL, Schiller I. Aerosolized steroids in bronchial asthma. J Allergy 1958; 29:214–221.
2. Moren F. Drug deposition of pressurized inhalation aerosols: influence of actuator tube design. Int J Pharm 1978; 1:205–212.
3. Corr D, Dolovich M, McCormack D, Ruffin R, Obminski G, Newhouse M. Design and characteristics of a protable breath actuated, particle size selective medical aerosol inhaler. J Aerosol Sci 1982; 13:1–7.
4. Bloomfield P, Crompton GK, Winsey NJP. A tube spacer to improve inhalation of drugs from pressurised aerosols. Br Med J 1979; 2:1479.
5. Bisgaard H, Olsson S. PEP-spacer: an adaptation for administration of metereddose inhalers to infants. Allergy 1989; 44:363–364.
6. O’Callaghan C, Milner AD, Swarbrick A. Spacer device with face mask attachment for giving bronchodilators to infants with asthma. Br Med J 1989; 298:160–161.
7. Conner WT, Dolovich MB, Frame RA, Newhouse MT. Reliable salbutamol administration in 6- to 36-month-old children by means of a metered dose inhaler and Aerochamber with mask. Pediatr Pulmonol 1989; 6:263–267.
8. Bisgaard H, Munck SL, Nielsen JP, Petersen W, Ohlsson SV. Inhaled budesonide for treatment of recurrent wheezing in early childhood. Lancet 1990; 336:649–651.
9. Kraemer R, Frey U, Sommer W, Russi E. Short-term effect of albuterol, delivered via a new auxiliary device in wheezy infants. Am Rev Respir Dis 1991; 144:347–351.
10. Kraemer R, Birrer P, Modelska K, Casaulta Aebischer C, Schöni MH. A new babyspacer device for aerosolized bronchodilator administration in infants with bronchopulmonary disease. Eur J Pediatr 1992; 151:57–60.
11. Clarke JR, Aston H, Silverman M. Delivery of salbutamol by metered dose inhaler and valved spacer to wheezy infants: effect on bronchial responsiveness. Arch Dis Child 1993;69:125–129.
12. Bisgaard H. Delivery of inhaled medication to children. J Asthma 1997; 34:443–468.
13. Kim CS, Eldridge A, Sackner MA. Oropharyngeal deposition and delivery aspects of metered-dose inhaler aerosols. Am Rev Respir Dis 1987; 135:157–164.
14. Ahrens R, Lux C, Bahl T, Han S-H. Choosing the metered-dose inhaler spacer or holding chamber that matches the patient’s need: evidence that the specific drug being delivered is an important consideration. J Allergy Clin Immunol 1995; 96:288–294.
15. Bisgaard H. Drug delivery from inhaler devices (Editorial). Br Med J 1996; 313:895–896.
16. Pedersen S. Aerosol treatment of bronchoconstriction in children with or without a tube spacer. N Engl J Med 1983; 308:1328–1330.
17. Lee H, Evans HE. Evaluation of inhalation aids of metered dose inhalers in asthmatic children. Chest 1987; 91:366–369.
18. König P. Spacer devices used with metered-dose inhalers—breakthrough or gimmick? Chest 1985; 88:276–284.
19. Pedersen S. Inhaler use in children with asthma. Danish Med Bull 1987; 34:234–249.
20. Salzman GA, Pyszczynski DR. Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with AeroChamber. J Allergy Clin Immunol 1988; 81:424–428.
21. Morgan M, Singh B, Frame M, Williams S. Terbutaline aerosol given through a pear spacer in acute severe asthma. Br Med J 1982; 285:849–850.
22. Fuglsang G, Pedersen S. Comparison of Nebuhaler and nebuliser treatment of acute severe asthma in children. Eur J Respir Dis 1986; 69:109–113.
23. Keeley D. Large volume plastic spacers in asthma (commentary). Br Med J 1992; 305:598–599.
24. Bisgaard H, Anhøj J, Klug B, Berg E. A non-electrostatic spacer for aerosol delivery. Arch Dis Child 1995; 73:226–230.
25. Zak M, Madsen J, Berg E, Bülow J, Bisgaard H. A mathematical model of aerosol holding chambers. J Aerosol Med 1999; 12: 187–196.
26. Levison H, Reilly PA, Worsley GH. Spacing devices and metered-dose inhalers in childhood asthma. J Pediatr 1985; 107:662–668.
27. Barry PW, O’Callaghan C. Inhalational drug delivery from seven different spacer devices. Thorax 1996; 51:835–840.
28. Lipworth BJ, Clark DJ. Early lung absorption profile of non-CFC salbutamol via small and large volume spacer devices. Br J Clin Pharmacol 1998; 46:45–48.
29. Barry PW, O’Callaghan C. In vitro comparison of the amount of salbutamol available for inhalation from different formulations used with different spacer devices. Eur Respir J 1997; 10:1345–1348.
30. Dhand R, Malik K, Balakrishnan M, Verma SR. High speed photographic analysis of aerosols produced by metered dose inhalers. J Pharm Pharmacol 1988; 40:429–480.
31. Laschka B, PernPeintner A. Strömungsverhalten bei “Rondo”—Ringwirbelvernebelung zur optimierten Dosier-Aerosol-Inhalation. Atemz Lungenkrkh 1990; 16:S40–S44.
32. O’Callaghan C, Lynch J, Cant M, Robertson C. Improvement in sodium cromoglycate delivery from a spacer device used of antistatic lining, immediate inhalation, and avoiding multiple actuations of drug. Thorax 1993; 48:603–606.
33. Bisgaard H. Dose of aerosol inhaled in young children from a small-volume spacer. Eur J Respir Dis 1993; 6:352.
34. Bisgaard H. A metal aerosol holding chamber devised for young children with asthma. Eur Respir J 1995; 8:856–860.
35. Janssens HM, Devadason SG, Hop WCJ, LeSouëf PN, De Jongste JC, Tiddens HAWM. Variability of aerosol delivery via spacer devices in young asthmatic children in daily life. Eur Respir J 1999; 13:787–791.
36. Dewsbury NJ, Kenyon CJ, Newman SP. The effect of handling techniques on electrostatic charge on spacer devices: a correlation with in vitro particle size analysis. Int J Pharm 1996; 137:261–264.
37. Wildhaber JH, Devadason SG, Hayden MJ, James R, Dufty AP, Fox RA, Summers QA, LeSouëf PN. Electrostatic charge on a plastic spacer device influences the delivery of salbutamol. Eur Respir J 1996; 9:1943–1946.
38. Berg E, Madsen, J, Bisgaard H. In vitro performance of three combinations of spacers and pressurized metered dose inhalers for treatment of children. Eur Respir J 1998; 12:472–476.
39. Anhøj J, Bisgaard H, Lipworth BJ. Effect of electrostatic charge in plastic spacers on the lung delivery of HFA-salbutamol in children. Br J Clin Pharmacol 1999; 47:333–336.
40. Clark DJ, Lipworth BJ. Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device. Thorax 1996;51:981–984.
41. Kenyon CJ, Thorsson L, Borgström L, Newman SP. The effects of static charge in spacer devices on glucocorticosteroid aerosol deposition in asthmatic patients. Eur Respir J 1998; 11:606–610.
42. Piérart F, Wildhaber JH, Vrancken I, Devadason SG, Le Souëf PN. Washing plastic spacers in household detergent reduces electrostatic charge and greatly improves delivery. Eur Respir J 1999; 13:673–678.
43. Barry PW, O’Callaghan C. The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler. Br J Clin Pharmacol 1995; 40:76–78.
44. Wildhaber JH, Devadason SG, Eber E, Hayden MJ, Everard ML, Summers QA, LeSoüef PN. Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants. Thorax 1996; 51:985–988.
45. Finlay WH, Zuberbuhler P. In vitro comparison of beclomethasone and salbutamol metered-dose inhaler aerosols inhaled during pediatric tidal breathing from four valved holding chambers. Chest 1998; 114:1676–1680.
46. Reilly PA, Yahav J, Mindorff C et al. Dose-response characteristics of nebulized fenoterol in asthmatic children. J Pediatr 1983; 103:121–126.
47. Harvey JE, Tattersfield AE. Airway response to salbutamol: effect of regular salbutamol inhalations in normal atopic and asthmatic subjects. Thorax 1982; 37:280–287.
48. Rivlin J, Mindorff C, Levison H, et al. Effect of administration technique on bronchodilator response to fenoterol in a metered dose inhaler. J Pediatr 1983; 102:470–472.
49. Shore SC, Weinberg EG. Administration of bronchodilator to young children. Br Med J 1973; 2:350.
50. Cushley MJ, Lewis RA, Tattersfield AE. Comparison of three techniques of inhalation on the airway response to terbutaline. Thorax 1983; 38:908–913.
51. Borgström L, Derom E, Ståhl E, Wåhlin-Boll E, Pauwels R. The inhalation device influences lung deposition and bronchodilating effect of terbutaline. Am J Respir Crit Care Med 1996; 153:1636–1640.
52. Dolovich M, Ruffin R, Corr D et al. Clinical evaluation of a simple demand inhalation MDI aerosol delivery device. Chest 1983; 84:36–41.
53. Ashurt IC, Ambrose CV, Russel DJ. Pharmaceutical evaluation of a new spacer device for delivery of metered-dose inhalers to infants and young children. J Aerosol Sci 1992; 23:S499–S502.
54. Agertoft L, Pedersen S. Influence of spacer device on drug delivery to young children with asthma. Arch Dis Child 1994; 71:217–220.
55. Mallol J, Barrueto L, Girardi G, Toro O. Bronchodilator effect of fenoterol and ipratropium bromide in infants with acute wheezing: use of pMDI with a spacer device. Pediatr Pulmonol 1987; 3:352–356.
56. Henry RL, Milner AD, Davies JG. Simple drug delivery system for use by young asthmatics. Br Med J 1983; 286:2021.
57. Yuksel B, Greenough A, Maconochie I. Effective bronchodilator treatment by a simple spacer device for wheezy premature infants. Arch Dis Child 1990; 65:782–785.
58. Sritara P, Janvitayanuchit S. Improvement of inhaler efficacy by home-made spacer. J Med Assoc Thai 1993; 76(12):693–697.
59. Zar HJ, Liebenberg M, Weinberg EG, Binns HJ, Mann MD. The efficacy of alternative spacer devices for delivery of aerosol therapy to children with asthma. Ann Trop Paediatr 1998; 18(2):75–79.
60. Berg E. In vitro properties of pressurized metered dose inhalers with and without spacer devices. J Aerosol Med 1995; 8(Suppl 3):3–11.
61. Thorsson L, Edsbäcker S. Lung deposition of budesonide from a pressurized metered- dose inhaler attached to a spacer. Eur Respir J 1998; 12:1340–1345.
62. Everard ML, Clark AR, Milner AD. Drug delivery from holding chambers with attached facemask. Arch Dis Child 1992; 67:580–585.
63. Barry PW, O’Callaghan C. Multiple actuations of salbutamol MDI into a spacer device reduce the amount of drug recovered in the respirable range. Eur Respir J 1994; 7:1707–1709.
64. Rau JL, Restrepo RD, Deshpande V. Inhalation of single vs multiple metered-dose bronchodilator actuations from reservoir devices. Chest 1996; 109;109:969–974.
65. Uhlig T, Eber E, Devadason SG, Pemberton P, Badawi N, LeSouëf PN, Wildhaber JH. Aerosol delivery to spontaneously breathing neonates: spacer or nebulizer? Pediatr Asthma Allergy Immunol 1997; 11:111–117.
66. Tal A, Golan H, Grauer N, Aviram M, Albin D, Quastel MR. Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction. J Pediatr 1996; 128:479–484.
67. Wildhaber JH, Dore ND, Wilson JM, Devadason SG, LeSouëf PN. Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children. J Pediatr 1999; 135:28–33.
68. Chua HL, Collis GG, Newbury AM, Chan K, Bower GD, Sly PD, Le Souëf PN. The influence of age on aerosol deposition in children with cystic fibrosis. Eur Respir J 1994; 7:2185–2191.
69. Becquemin MH, Swift DL, Bouchikhi A, Roy M, Teillac A. Particle deposition and resistance in the nose of adults and children. Eur Respir J 1991; 4:694–702.
70. Zar HJ, Weinberg EG, Binns HJ, Gallie F, Mann MD. Lung deposition of aerosol—a comparison of different spacers. Arch Dis Child 2000; 82(6):495–498.
71. Wilkie RA, Bryan MH. Effect of bronchodilators on airway resistance in ventilator- dependent neonates with chronic lung disease. J Pediatr 1987; 111:278–282.
72. Lee H, Arnon S, Silverman M. Bronchodilator aerosol administered by metered dose inhaler and spacer in subacute neonatal respiratory distress syndrome. Arch Dis Child 1994; 70:F218–F222.
73. Gappa M, Gartner M, Poets CF, von der Hardt H. Effects of salbutamol delivery from a metered dose inhaler versus jet nebulizer on dynamic lung mechanics in very preterm infants with chronic lung disease. Pediatr Pulmonol 1997; 23:442–448.
74. Yuksel B, Greenough A. Randomised trial of inhaled steroids in preterm infants with respiratory symptoms at follow up. Thorax 1992; 47:910–913.
75. Fisher JT, Mortola JP, Smith JB, Fox GS, Weeks S. Respiration in newborns: development of the control of breathing. Am Rev Respir Dis 1982; 125:650–657.
76. Benito-Zaballos MP, Pedraz Garcia C, Salazar A, Villalobos V. Pulmonary function in preterm and full term infants during the neonatal period: 1. Respiratory pattern. Ann Esp Ped 1991; 35:243–247.
77. Riedler J, Robertson CF. Effect of tidal volume on the output and particle size distribution of hypertonic saline from an ultrasonic nebulizer. Eur Resp J 1994; 7:998–1002.
78. Marsh MJ, Ingram D, Milner AD. The effect of instrumental dead space on measurement of breathing pattern and pulmonary mechanics in the newborn. Pediatr Pulmonol 1993; 16:316–322.
79. Fok TF, Monkman S, Dolovich M, Gray S, Coates G, Paes B, Rashid F, Newhouse M, Kirpalani H, Efficiency of aerosol medication delivery from a metered dose inhaler versus jet nebulizer in infants with bronchopulmonary dysplasia. Pediatr Pulmonol 1996; 21:301–309.
80. Rau JL, Harwood RJ, Groff JL. Evaluation of a reservoir device for metered-dose bronchodilator delivery to intubated adults: an in vitro study. Chest 1992; 102:924–930.
81. Wildhaber JH, Hayden MJ, Dore ND, Devadason SG, LeSouëf PN. Salbutamol delivery from a HFA pMDI in paediatric ventilator circuits. An in vitro study. Chest 1998; 113:186–191.
82. Diot P, Morra L, Smaldone GC. Albuterol delivery in a model of mechanical ventilation: comparison of metered-dose inhaler and nebulizer efficiency. Am J Respir Crit Care Med 1995; 152:1391–1394.
83. Everard ML, Stammers J, Hardy JG, Milner AD. New aerosol delivery system for neonatal ventilator circuits. Arch Dis Child 1992; 67:826–830.
84. Fink JB, Dhand R, Duarte AGJenne JW, Tobin MJ. Aerosol delivery from a metered- dose inhaler during mechanical ventilation: an in vitro model. Am J Respir Crit Care Med 1996; 154:382–387.
85. Fuller HD, Dolovich MB, Chambers C, Newhouse MT. Aerosol delivery during mechanical ventilation: a predictive in-vitro lung model. J Aerosol Med 1992; 5:251–259.
86. Arnon S, Grigg J, Nikander K, Silverman M. Delivery of micronized budesonide suspension by metered dose inhaler and jet nebulizer into a neonatal ventilator circuit. Pediatr Pulmonol 1992; 13:172–175.
87. Gay PC, Patel HG, Nelson SB, Gilles B, Hubmayr RD. Metered dose inhalers for bronchodilator delivery in intubated, mechanically ventilated patients. Chest 1991; 99:66–71.
88. Fuller HD, Dolovich MB, Posmituck G, Pack WW, Newhouse MT. Pressurised aerosol versus jet aerosol delivery to mechanically ventilated patients. Am Rev Respir Dis 1990; 141:440–444.
89. Sivakumar D, Bosque E, Goldman SL. Bronchodilator delivered by metered dose inhaler and spacer improves respiratory system compliance more than nebulizerdelivered bronchodilator in ventilated premature infants. Pediatr Pulmonol 1999; 27:208–212.
90. Newman SP, Steed K, Hooper G, Källén A, Borgström L. Comparison of gamma scintigraphy and a pharmacokinetic technique for assessing pulmonary deposition of terbutaline sulphate delivered by pressurized metered dose inhaler. Pharm Res 1995; 12:231–236.
91. Vidgren P, Vidgren M, Paronen P, Vainio P, Nuutinen J. Effects of inspirease holding chamber on the deposition of metered dose inhalation aerosols. Eur J Drug Metab Pharmacokinet 1991; 3:419–425.
92. Thorsson L, Kenyon C, Newman SP, Borgström L. Lung deposition of budesonide in asthmatics: a comparison of different formulations. Int J Pharm 1998: 119–127.
93. Melchor R, Biddiscombe MF, Mak VHF, Short MD, Spiro SG. Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction. Thorax 1993; 48:506–511.
94. Tobin MT, Jenouri G, Danta I, Kim CS, Watson H, Sackner MA. Response to bronchodilator drug administration by a new reservoir aerosol delivery system and a review of other auxiliary systems. Am Rev Respir Dis 1982; 126:670–675.
95. Morris J, Milledge JS, Moszoro H, Higgins A. The efficacy of drug delivery by a pear-shaped spacer and metered dose inhaler. Br J Dis Chest 1984; 78:383–389.
96. Hindle M, Chrystyn H. Nebuhaler and volumatic improve pulmonary delivery. Arch Dis Child 1992;67:580–585.
97. Fuglsang G, Pedersen S. Cumulative dose response relationship of terbutaline delivered by three different inhalers. Allergy 1988;43:348–352.
98. Gurwitz D, Levison H, Mindorff C, Reilly P, Worsley G. Assessment of a new device (Aerochamber) for use with aerosol drugs in asthmatic children. Ann Allergy 1983; 50:166–170.
99. Anhøj J, Thorsson L, Bisgaard H. Lung deposition of inhaled drugs increases with age. Am J Respir Crit Care Med 2000.
100. Bisgaard H. Automatic actuation of a dry powder inhaler into a nonelectrostatic spacer. Am J Respir Crit Care Med 1998; 157:518–521.